Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-05-31
1997-05-06
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514521, 514523, 514525, 558401, A61K 31275, C07C25530
Patent
active
056272073
ABSTRACT:
The present invention provides compounds of the formula ##STR1## wherein Y is a naphthyl, tetrahydronaphthyl, pyridyl, quinolyl, isoquinolyl or indolyl ring system, R is a moiety which is an acrylic acid, a CN-substituted acrylic acid, acrylamide, acrylonitrile or thioacrylamide, or a group of formulae (e) to (j): ##STR2## wherein R.sub.3 is OH or NH.sub.2, R.sub.1 is H, alkyl or alkanoyl, R.sub.2 is H, halogen, CN or alkyl; and n is 0, 1, 2 or 3; and the pharmaceutically acceptable salts thereof are useful as tyrosine kinase inhibitors.
REFERENCES:
patent: 5122537 (1992-06-01), Buzzetti et al.
patent: 5130472 (1992-07-01), Buzzetti et al.
patent: 5374652 (1994-12-01), Buzzetti et al.
patent: 5397787 (1995-03-01), Buzzetti et al.
patent: 5409949 (1995-04-01), Buzzetti et al.
Nagai, Nagoya Kogyo Daigaku Gakuho, vol. 22, 1970 pp. 143-149.
Buzzetti Franco
Colombo Maristella
Longo Antonio
Davis Zinna Northington
Farmitalia Carlo Erba S r l
LandOfFree
Arylethenylene compounds which are useful as tyrosine kinase inh does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylethenylene compounds which are useful as tyrosine kinase inh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylethenylene compounds which are useful as tyrosine kinase inh will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2133040